The diagnostic pitfalls of mucormycosis
ConclusionsThis case showed that also intensive chemotherapy with rituximab may represent a risk factor for mucormycosis infection. Liposomal amphotericin B and surgery remain key tools for a successful treatment of this aggressive disease.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Margherita Mauro, Giuliana Lo Cascio, Rita Balter, Ada Zaccaron, Elisa Bonetti, Virgina Vitale, Matteo Chinello, Massimiliano De Bortoli, Paolo Brazzarola, Costanza Bruno, Simone Cesaro Source Type: research
More News: Abelcet | Aspergillosis | Chemotherapy | Children | Hematology | Hodgkin's Disease | Infectious Diseases | Lymphoma | Non-Hodgkin's Lymphoma | Pediatrics | Rituxan | Thyroid | Urology & Nephrology